Table 1.

Association between DACT2 expression and clinical pathologic parameters in ESCC

DACT2 expression
Clinical parametersNegativePositiveP
Age, y
 ≤5737 (50.0%)43 (47.8%)0.875
 >5737 (50.0%)47 (52.2%)
Gender
 Male51 (68.9%)70 (77.8%)0.216
 Female23 (31.1%)20 (22.2%)
Tumor size
 ≤3 cm32 (43.2%)44 (48.9%)0.764
 3–5 cm32 (43.2%)34 (37.8%)
 >5 cm10 (13.6%)12 (13.3%)
Differentiation
 G113 (17.6%)34 (37.8%)0.008
 G252 (70.3%)52 (57.8%)
 G39 (12.1%)4 (4.4%)
Invasive depth
 T1 + T25 (6.8%)5 (6.7%)1.000
 T3 + T469 (93.2%)85 (93.3%)
LN Metastasis
 N037 (50.0%)52 (57.8%)0.347
 N1 + N2 + N337 (50.0%)38 (42.2%)
TNM Classification
 I + II41 (55.4%)52 (57.8%)0.874
 III + IV33 (44.6%)38 (42.2%)

NOTE: Statistical analysis: the Kendall tall-b test LN: lymph node.

Negative: 0 to 6; positive: 7 to 12. Bold: p < 0.05.